Sanofi (NASDAQ:SNY) is one of the best pharma stocks to invest in. Sanofi (NASDAQ:SNY) was downgraded to Neutral from ...

Sarepta Therapeutics (NASDAQ:SRPT) leads in genetic therapies, contributing to ongoing discussions surrounding the nasdaq ...

(Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder, will ...

Senti Bio reports encouraging SENTI-202 AML trial results as the FDA grants RMAT status, with strong response rates, durable ...

Summary • Origin Agritech Limited’s shares fell 6.8% to $1.45 in after-hours trading, declining from $1.56.• The company was ...

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Both stocks are risky, but one is far less so. This juicy upside potential comes at a cost. Investors seeking stocks with ...

So far, the company's commercialized drugs have delivered billions of dollars in revenue. For example, in the latest quarter, ...

Explore Precision BioSciences' advances in gene therapy for hepatitis B, strong funding till 2028, and what it means for ...

Although there are thousands of ETFs that owe their gains to Magnificent 7 AI stocks, these 2 ETFs have superior gains ...